Jane Street’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-48,371
| Closed | -$4.76M | – | 10702 |
|
|
2025
Q2 | $4.76M | Sell |
48,371
-17,194
| -26% | -$1.63M | ﹤0.01% | 3066 |
|
|
2025
Q1 | $6.07M | Buy |
65,565
+9,892
| +18% | +$912K | ﹤0.01% | 2640 |
|
|
2024
Q4 | $5.05M | Buy |
+55,673
| New | +$5.11M | ﹤0.01% | 2644 |
|
|
2024
Q3 | – | Sell |
-8,565
| Closed | -$786K | – | 9516 |
|
|
2024
Q2 | $786K | Buy |
8,565
+5,111
| +148% | +$474K | ﹤0.01% | 6238 |
|
|
2024
Q1 | $318K | Sell |
3,454
-3,070
| -47% | -$288K | ﹤0.01% | 7461 |
|
|
2023
Q4 | $620K | Sell |
6,524
-33,452
| -84% | -$3.12M | ﹤0.01% | 6389 |
|
|
2023
Q3 | $3.73M | Buy |
39,976
+24,059
| +151% | +$2.22M | ﹤0.01% | 3031 |
|
|
2023
Q2 | $1.46M | Sell |
15,917
-33,021
| -67% | -$2.71M | ﹤0.01% | 4635 |
|
|
2023
Q1 | $3.6M | Buy |
48,938
+43,677
| +830% | +$3.78M | ﹤0.01% | 2891 |
|
|
2022
Q4 | $440K | Sell |
5,261
-17,461
| -77% | -$1.57M | ﹤0.01% | 6358 |
|
|
2022
Q3 | $2.2M | Sell |
22,722
-21,285
| -48% | -$2.54M | ﹤0.01% | 4047 |
|
|
2022
Q2 | $4.63M | Buy |
44,007
+40,679
| +1,222% | +$5.2M | ﹤0.01% | 2784 |
|
|
2022
Q1 | $573K | Sell |
3,328
-10,006
| -75% | -$1.49M | ﹤0.01% | 7210 |
|
|
2021
Q4 | $2.16M | Sell |
13,334
-32,139
| -71% | -$5.17M | ﹤0.01% | 4328 |
|
|
2021
Q3 | $6.78M | Buy |
45,473
+40,080
| +743% | +$8.33M | ﹤0.01% | 2305 |
|
|
2021
Q2 | $1.32M | Sell |
5,393
-1,627
| -23% | -$427K | ﹤0.01% | 5209 |
|
|
2021
Q1 | $1.86M | Sell |
7,020
-3,786
| -35% | -$1.07M | ﹤0.01% | 4158 |
|
|
2020
Q4 | $3.17M | Sell |
10,806
-11,386
| -51% | -$2.92M | ﹤0.01% | 2748 |
|
|
2020
Q3 | $5.25M | Sell |
22,192
-55,917
| -72% | -$12.7M | ﹤0.01% | 1798 |
|
|
2020
Q2 | $15.5M | Buy |
78,109
+76,708
| +5,475% | +$14.3M | 0.01% | 889 |
|
|
2020
Q1 | $257K | Sell |
1,401
-1,066
| -43% | -$190K | ﹤0.01% | 4380 |
|
|
2019
Q4 | $411K | Sell |
2,467
-2,312
| -48% | -$344K | ﹤0.01% | 3918 |
|
|
2019
Q3 | $626K | Buy |
+4,779
| New | +$622K | ﹤0.01% | 3243 |
|
|
2018
Q4 | – | Sell |
-4,424
| Closed | -$553K | – | 4878 |
|
|
2018
Q3 | $553K | Buy |
+4,424
| New | +$489K | ﹤0.01% | 3496 |
|
|
2017
Q2 | – | Sell |
-4,444
| Closed | -$227K | – | 4280 |
|
|
2017
Q1 | $227K | Buy |
+4,444
| New | +$212K | ﹤0.01% | 3734 |
|
|
2014
Q3 | – | Sell |
-10,817
| Closed | -$181K | – | 2505 |
|
|
2014
Q2 | $181K | Buy |
+10,817
| New | +$153K | ﹤0.01% | 2240 |
|
Other funds holding AMED
IA
MCI
HNB
Jane Street's AMED Position: Q3 2025 in Review
Jane Street sold out of Amedisys (AMED) in Q3 2025, closing a stake of 48,371 shares — an estimated $4.76M sold.
Jane Street first reported a position in AMED in Q2 2014 and held it in 26 quarters. The position peaked at $15.5M in Q2 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Jane Street reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Jane Street sold 48,371 Amedisys shares in Q3 2025, an estimated $4.76M.
- Jane Street first reported a position in Amedisys in Q2 2014 and held it in 26 quarters.
- Jane Street's Amedisys position peaked at $15.5M in Q2 2020.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.